Vendor Intelligence Report: TSC Top Supplements China
Published 12 Nov 2026. 32-page investigative report on who is behind TSC Top Supplements China: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.
Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.
Executive summary
TSC Top Supplements China is a product-specific case, not a one-word vendor verdict. The supplied Finnrick record covers 147 lab tests, 106 pass / 40 fail, for a 72% overall pass rate. The spread is the point: GHK-Cu is the clear strength, Retatrutide and Tirzepatide are conditional higher-volume choices with underfill and identity-failure outliers, and TB-500 is the clearest avoid signal. Ratings also contract under stricter fill and purity thresholds.
The public operating trail is thinner than the lab trail. The only published contact route, Discord invite 4FDtknmBVW, now returns an expired-invite API response; Peptigrity marks the Discord as Report dead; and a forum record lists multiple TSC-linked Discord servers in a suspension wave. In public sources reviewed, no legal entity, owner, address, official domain, refund policy, merchant identity or named technical decision-maker was identified.
Search visibility creates a separate authentication problem. Exact-match TSC domains registered during the refresh are parked and not verified as official, while AI-generated TSC keyword pages carry shifting location claims and lead into a rotating WhatsApp catalog funnel. The report keeps that funnel separate from TSC because no control link is proven, but it shows why buyers need a validated channel before trusting a seller or COA.
Directory scores do not settle the question. One low score is driven largely by an overseas-supplier adjustment, another profile labels TSC as US despite China metadata, and a broader product catalog may be real inventory or attribution drift. The useful read is product-by-product quality plus channel authentication and recourse.
Inside the full report:
- Appendix A with per-product pass/fail rates and methodology-divergence charts for all 9 Finnrick product lines
- Discord invite API evidence, Peptigrity dead-channel marker and GLP-1 Forum suspension record
- Registry, ownership and RDAP review covering unresolved legal identity and parked exact-match domains
- Brand-confusion analysis of AI-spam hosts, shifting location claims and the WhatsApp redirect funnel
- Aggregator reconciliation across PeptideBenchmark, PeptideAtlas, TriedRx, PeptideMeter, VerifiedPure, ASCEND, ONPEPS and Peptigrity
- Traceability analysis of batch-ID formats, no-label vials and COA-matching limits
Risk assessment
- No live public contact channel — high: Discord invite 4FDtknmBVW returns 'Invite is expired'; Peptigrity records 'Report dead'; no replacement channel found.
- Corporate opacity and buyer-recourse risk — high: No legal entity, address, owner, refund policy, merchant identity or canonical website found; disputes lack a public counterparty.
- Platform-continuity risk — high: Four TSC-linked Discord servers were reported suspended in Nov 2025 and the primary invite is now expired; order, support and COA records can disappear.
- Brand-confusion and impersonation risk — high: AI spam pages, fabricated location claims, a 14-number WhatsApp funnel and parked exact-match domains target TSC searches without official verification infrastructure.
- Traceability and batch-matching risk — high: Many tested vials were no-label or no-batch-ID and observed batch IDs use inconsistent formats, limiting reliable COA matching and recall.
- Product-quality risk — TB-500 — high: TB-500 has 5 tests, 0 pass, 5 fail and a 29.78% rating; no passing test in the supplied row.
- Product-quality risk — BPC-157 — high: BPC-157 has 15 tests, 6 pass, 9 fail and a 44.33% rating; identity failure recorded 10 Sep 2025.
- Product-quality risk — Tesamorelin — high: Tesamorelin has 9 tests, 4 pass, 5 fail and a 47.62% rating; severe underfill/purity failure and identity failure are documented.
- Product-quality risk — Semaglutide and Cagrilintide — medium: Semaglutide is 1/4 pass at 58.98%; Cagrilintide is 4/6 pass at 57.61%; both are thin and unfavorable.
- Product-quality risk — Retatrutide and Tirzepatide — medium: Retatrutide is 51/62 pass at 81.78% and Tirzepatide is 26/31 pass at 82.07%, but both have severe underfill or identity-failure outliers.